Pharma biz seeks clearance of imported APIs, medical devices
The strict customs scrutiny and non-clearance of imports from China has now hit the pharmaceutical sector -- the lifeline amid the pandemic -- making industry representatives to reach out to the government and seek urgent clearance of the goods at ports and airports.
migrator
New Delhi
In a communication to the Secretary, Department of Pharmaceuticals, the Pharmaceutical Export Promotion Council of India (Pharmexcil) said it has been inundated with distress calls from its member companies over an acute disruption in manufacturing of pharmaceutical products over the last three days.
The letter was also marked to the PMO and the Directorate General of Foreign Trade among others. “Very critical KSM’s (Key Starting Material), intermediates & API’s (Active Pharmaceutical Ingredients) are not being cleared for the reasons not known to the industry at all,” said the letter by Dinesh Dua, Chairman, Pharmexcil. Even critical devices such as ‘infrared thermometers’ and ‘pulse oximeters’ which are specifically aimed at COVID-19 diagnosis as also ‘glucometers’ and ‘strips’ are also held up at the Delhi airport, he said. The self reliance or the “Aatmanirbhar” principle will take its own time in a phased and considered manner through the Centre’s incentives such as ‘pharma parks’ as also production linked incentives’ (PLI).
Visit news.dtnext.in to explore our interactive epaper!
Download the DT Next app for more exciting features!
Click here for iOS
Click here for Android
